文献速递膀胱癌与上尿路尿路上皮癌

微创肾输尿管切除术后膀胱内复发的危险因素:ROBUUST协作研究

Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
PubMed 文献 · J Urol · 2021-04-21

该多中心回顾性研究纳入485例无膀胱癌病史的上尿路尿路上皮癌患者,均接受机器人或腹腔镜肾输尿管切除术。术后22.7%发生膀胱内复发,平均时间15.2个月。多因素分析显示高血压、诊断性输尿管镜活检、膀胱袖状切除经尿道电切及手术切缘阳性是独立危险因素。

要点

  • 微创肾输尿管切除术后膀胱内复发率22.7%,平均15.2个月。
  • 高血压、输尿管镜活检、经尿道膀胱袖切除、切缘阳性增加复发风险。
  • 避免经尿道膀胱袖切除、优化活检策略或可降低复发。

核心结论

  • 微创肾输尿管切除术后膀胱内复发较常见,危险因素包括输尿管镜活检、经尿道膀胱袖切除和切缘阳性。

研究设计与样本

  • 多中心回顾性分析纳入485例无膀胱癌病史的上尿路尿路上皮癌患者,均接受机器人或腹腔镜肾输尿管切除术,来自美国、欧洲和亚洲17家机构。

主要发现

  • 110例(22.7%)发生膀胱内复发,平均复发时间15.2个月(标准差15.5个月)。

临床怎么用

  • 对于上尿路尿路上皮癌行微创肾输尿管切除术的患者,应评估高血压等危险因素。
  • 尽可能避免经尿道膀胱袖切除,并考虑替代活检策略以减少膀胱内复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Intravesical recurrence (IVR) after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) has an incidence of approximately 20%-50%. Studies to date have been composed of mixed treatment cohorts-open, laparoscopic and robotic. The objective of this study is to assess clinicopathological risk factors for intravesical recurrence after RNU for UTUC in a completely minimally invasive cohort. MATERIALS AND METHODS: We performed a multicenter, retrospective analysis of 485 patients with UTUC without prior or concurrent bladder cancer who underwent robotic or laparoscopic RNU. Patients were selected from an international cohort of 17 institutions across the United States, Europe and Asia. Univariate and multiple Cox regression models were used to identify risk factors for bladder recurrence. RESULTS: A total of 485 (396 robotic, 89 laparoscopic) patients were included in analysis. Overall, 110 (22.7%) of patients developed IVR. The average time to recurrence was 15.2 months (SD 15.5 months). Hypertension was a significant risk factor on multiple regression (HR 1.99, CI 1.06; 3.71, p=0.030). Diagnostic ureteroscopic biopsy incurred a 50% higher chance of developing IVR (HR 1.49, CI 1.00; 2.20, p=0.048). Treatment specific risk factors included positive surgical margins (HR 3.36, CI 1.36; 8.33, p=0.009) and transurethral resection for bladder cuff management (HR 2.73, CI 1.10; 6.76, p=0.031). CONCLUSIONS: IVR after minimally invasive RNU for UTUC is a relatively common event. Risk factors include a ureteroscopic biopsy, transurethral resection of the bladder cuff, and positive surgical margins. When possible, avoidance of transurethral resection of the bladder cuff and alternative strategies for obtaining biopsy tissue sample should be considered.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Katims AB, Say R, Derweesh I, et al. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration). J Urol. 2021. PMID: 33881931. doi:10.1097/JU.0000000000001786

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。